PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 32 filers reported holding PROTARA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,666 | -45.0% | 27,345 | -21.3% | 0.00% | – |
| Q2 2023 | $83,041 | -25.8% | 34,745 | -2.8% | 0.00% | – |
| Q1 2023 | $111,882 | -9.5% | 35,745 | -22.5% | 0.00% | – |
| Q4 2022 | $123,674 | -18.1% | 46,147 | -9.6% | 0.00% | -100.0% |
| Q3 2022 | $151,000 | -3.8% | 51,048 | -4.7% | 0.00% | 0.0% |
| Q2 2022 | $157,000 | -65.4% | 53,548 | -39.7% | 0.00% | 0.0% |
| Q1 2022 | $454,000 | -64.6% | 88,779 | -53.3% | 0.00% | -66.7% |
| Q4 2021 | $1,284,000 | +41.7% | 190,278 | +45.3% | 0.00% | +50.0% |
| Q3 2021 | $906,000 | +67.8% | 130,935 | +136.3% | 0.00% | +100.0% |
| Q2 2021 | $540,000 | -22.0% | 55,405 | +93.7% | 0.00% | -50.0% |
| Q4 2020 | $692,000 | +307.1% | 28,599 | +182.6% | 0.00% | +100.0% |
| Q3 2020 | $170,000 | – | 10,119 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,692,594 | $4,496,632 | 1.46% |
| Privium Fund Management (UK) Ltd | 119,730 | $201,146 | 0.16% |
| Ikarian Capital, LLC | 188,664 | $315,069 | 0.04% |
| Orbimed Advisors | 772,584 | $1,290,215 | 0.03% |
| Boxer Capital, LLC | 209,227 | $349,409 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $106,880 | 0.00% |
| Baker Brothers Advisors | 199,671 | $333,451 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,864 | $31,503 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 27,345 | $45,666 | 0.00% |
| OSAIC HOLDINGS, INC. | 100 | $167 | 0.00% |